Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cemtrex (CETXP) Shares Outstanding (2016 - 2025)

Cemtrex's Shares Outstanding history spans 16 years, with the latest figure at $8.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 233.36% year-over-year to $8.6 million; the TTM value through Dec 2025 reached $8.6 million, up 233.36%, while the annual FY2025 figure was $830606.0, 66.19% down from the prior year.
  • Shares Outstanding reached $8.6 million in Q4 2025 per CETXP's latest filing, up from $830606.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $18.7 million in Q2 2021 to a low of $503.0 in Q4 2023.
  • Average Shares Outstanding over 5 years is $2.6 million, with a median of $2.1 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding: crashed 99.98% in 2022, then surged 13788.89% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $2.0 million in 2021, then rose by 10.29% to $2.2 million in 2022, then tumbled by 97.71% to $50000.0 in 2023, then soared by 5059.99% to $2.6 million in 2024, then skyrocketed by 233.36% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for CETXP's Shares Outstanding are $8.6 million (Q4 2025), $830606.0 (Q3 2025), and $3.5 million (Q2 2025).